Long-term efficacy and adverse effects of cannabidiol in adjuvant treatment of drug-resistant epilepsy: a systematic review and meta-analysis

BACKGROUND: Epilepsy is one of the most common chronic brain diseases. Almost one-third of patients have drug-resistant epilepsy (DRE). Cannabidiol is being considered as a potential novel drug for treating DRE. OBJECTIVES: To investigate long-term efficacy and safety of cannabidiol in treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shengyi, He, Zihua, Li, Jinmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617284/
https://www.ncbi.nlm.nih.gov/pubmed/37915501
http://dx.doi.org/10.1177/17562864231207755

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617284/
https://www.ncbi.nlm.nih.gov/pubmed/37915501
http://dx.doi.org/10.1177/17562864231207755

Ejemplares similares